Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

QGEN

Qiagen NV (QGEN)

Qiagen NV
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:QGEN
DateTimeSourceHeadlineSymbolCompany
03/29/20217:47AMTipRanksFDA Approves Emergency Use For QIAGEN’s NeuMoDx Multiplex TestNYSE:QGENQiagen NV
03/29/20212:00AMBusiness WireQIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 PortfolioNYSE:QGENQiagen NV
03/26/20214:20PMEdgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:QGENQiagen NV
03/05/20216:05AMBusiness WireQIAGEN Announces 20-F Annual Report Filing for 2020 ResultsNYSE:QGENQiagen NV
03/05/20216:04AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:QGENQiagen NV
03/05/20216:01AMEdgar (US Regulatory)Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)NYSE:QGENQiagen NV
03/03/20214:10PMBusiness WireQIAGEN Launches QIAsphere Cloud-Based Connectivity Solution to Enhance QIAstat-Dx Capabilities in Digital DiagnosticsNYSE:QGENQiagen NV
03/03/20214:10PMBusiness WireQIAGEN bringt cloudbasierte Konnektivitätslösung QIAsphere auf den Markt und erweitert damit die QIAstat-Dx-Funktionalität...NYSE:QGENQiagen NV
03/02/20214:11PMBusiness WireQIAGEN Launches QIAcube Connect MDx Platform for Automated Sample Processing in Diagnostic LabsNYSE:QGENQiagen NV
03/02/20214:11PMBusiness WireQIAGEN bringt die QIAcube-Connect-MDx-Plattform für die automatisierte Probenverarbeitung in Diagnostik-Laboren auf den MarktNYSE:QGENQiagen NV
02/24/20214:19PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:QGENQiagen NV
02/24/20211:45AMPR Newswire (US)INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100...NYSE:QGENQiagen NV
02/24/20211:45AMBusiness WireQIAGEN & INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO’s VGX-3100...NYSE:QGENQiagen NV
02/24/20211:45AMBusiness WireQIAGEN und INOVIO erweitern Zusammenarbeit zur Entwicklung von NGS-Begleitdiagnostik für VGX-3100 von INOVIO für fortgeschr...NYSE:QGENQiagen NV
02/22/20214:08PMBusiness WireQIAGEN Expands Supervisory Board With Appointment of a New MemberNYSE:QGENQiagen NV
02/22/20214:08PMBusiness WireQIAGEN erweitert Aufsichtsrat um neues MitgliedNYSE:QGENQiagen NV
02/10/20216:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:QGENQiagen NV
02/09/20214:05PMBusiness WireQIAGEN Beats Outlook for Fourth Quarter and Full-Year 2020, Reaffirms Expectations for Further Growth in 2021NYSE:QGENQiagen NV
02/09/20214:05PMBusiness WireQIAGEN übertrifft Prognose für das vierte Quartal und das Gesamtjahr 2020 und bestätigt die Erwartung für weiteres Wachst...NYSE:QGENQiagen NV
02/03/20211:22PMEdgar (US Regulatory)Schedule 13gNYSE:QGENQiagen NV
01/28/20214:05PMBusiness WireQIAGEN Adds dPCR Platform QIAcuity to Growing Portfolio of COVID-19 Testing Solutions for Wastewater and Mutation TestingNYSE:QGENQiagen NV
01/28/20214:05PMBusiness WireQIAGEN erweitert wachsendes Portfolio von COVID-19 Testlösungen um dPCR-Plattform QIAcuity für Abwasser- und MutationstestsNYSE:QGENQiagen NV
01/26/20212:21PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:QGENQiagen NV
01/26/20217:10AMBusiness WireQIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 ResultsNYSE:QGENQiagen NV
01/22/20215:01PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:QGENQiagen NV
01/20/20214:08PMBusiness WireQIAGEN plant in den USA erneute Einreichung eines Antrags auf Notfallzulassung für den QIAreach SARS-CoV-2 Antigen Test im e...NYSE:QGENQiagen NV
01/20/20214:08PMBusiness WireQIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021NYSE:QGENQiagen NV
01/20/20214:05PMBusiness WireQIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the CoronavirusNYSE:QGENQiagen NV
01/20/20214:05PMBusiness WireQIAGEN bestätigt Wirksamkeit seiner SARS-CoV-2 PCR-Tests angesichts neuer Mutationen des CoronavirusNYSE:QGENQiagen NV
01/08/20214:45PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:QGENQiagen NV
 Showing the most relevant articles for your search:NYSE:QGEN

Your Recent History

Delayed Upgrade Clock